The function of immunosuppressive checkpoints in T cells, including programmed cell death protein (PD-1) and cytotoxic T lymphocyte (CTL)-associated protein 4 (CTLA-4), provides a basis for tumor immunotherapy. This evidence concerns the gene CTLA4 and neoplasm.